SARS-CoV-2 diagnostic pipeline
FIND is collating an overview of SARS-CoV-2 tests that are commercially available or in development for the diagnosis of COVID-19.
For all commercialized immunoassays and molecular tests, we have compiled a fully searchable directory. Manufacturer performance data (sensitivity and specificity) are included, where known, alongside data from independent evaluations conducted by FIND, where applicable.
COVID-19 TEST DIRECTORY (Immunoassays, MOLECULAR tests)
For all immunoassays and molecular tests in development, please refer to the list below. This pipeline tracker also has information on other diagnostic tools such as digital solutions and sample collection devices.
The list below was compiled from information submitted voluntarily by test suppliers and is not independently verified. If you have any queries or wish for us to make updates in this pipeline, please contact us.
To know more about the FIND evaluations of submitted SARS-CoV-2 tests, click here. ongoing test evaluations
- Beijing Infervision Technology Co. Ltd InferRead CT Pneumonia (In development)
- Canary Health Technologies AiroStotleCV19 (Breath VOCs) (In development)
- Finbiosoft Results Manager (automatic PCR interpretation software) (RUO)
- Intrasense SA Myrian Covid-19 (China NMPA EUA - US FDA EUA - CE-IVD)
- Jetware SRL LOMT - Pool Testing Management Software (In development)
- L7 Informatics Enterprise Science Platform (CLIA)
- Saturn Pass Saturn Pass Mobile App (MHRA UK - CE-IVD)
- Visible Patient Visible Patient Service - numerical (medical image analysis, CT or MRI) (US FDA 501(k) - CE Class IIa)